Evado launches into Asia

By Staff Writers
Wednesday, 22 October, 2008

Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.

Evado is being distributed by local clinical research company SeerPharma.

Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.

It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.

Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.

Related News

Stress disrupts emotion control in mental illness

Acute stress may impair key brain functions involved in managing emotions — particularly in...

Organoid platform enables closer study of bat-borne viruses

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...

Global study finds 250 genes linked to OCD

Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd